GINA VINES: Open Payments
NPI 1366092074 · OLDSMAR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,327 in 11 payments from 11 companies in 2025. Trend: 2023 $142 · 2024 $823 · 2025 $1,327
Food & beverage: $1,327
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 1 | $138 |
| Dexcom, Inc. | 1 | $130 |
| Boston Scientific Corporation | 1 | $129 |
| Corcept Therapeutics | 1 | $127 |
| GENZYME CORPORATION | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $124 |
| SANOFI-AVENTIS U.S. LLC | 1 | $120 |
| ARGENX US, INC. | 1 | $116 |
| Novo Nordisk Inc | 1 | $116 |
| SANOFI PASTEUR INC. | 1 | $103 |
Products named: Barostim Neo System, DEXCOM G7 GSS (161), WATCHMAN FLX, Korlym, CERDELGA, INGREZZA, TZIELD, VYVGART.
Industry payments across FL — which companies pay providers there.
